Skip to main navigation Skip to search Skip to main content

Comparison of the simplexa flua/b & rsv direct assay and laboratory-developed real-time pcr assays for detection of respiratory virus

  • Mitchell W. Woodberry*
  • , Rohit Shankar
  • , Anne Cent
  • , Keith R. Jerome
  • , Jane Kuypers
  • *Corresponding author for this work
  • University of Washington
  • United States Army
  • Department of Laboratory Medicine

Research output: Contribution to journalArticlepeer-review

Abstract

The results of the Focus Simplexa FluA/B & RSV Direct assay were compared to those of laboratory-developed reverse transcription PCR tests for 498 nasopharyngeal swabs.Concordance rates were 96.6% (476/493;-0.91), 97.6% (481/493;-0.47), and 99.2% (488/492;-0.94) for influenza A, influenza B, and respiratory syncytial virus, respectively

Original languageEnglish
Pages (from-to)3883-3885
Number of pages3
JournalJournal of Clinical Microbiology
Volume51
Issue number11
DOIs
Publication statusPublished - Nov 2013
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

ASJC Scopus subject areas

  • Microbiology (medical)

Fingerprint

Dive into the research topics of 'Comparison of the simplexa flua/b & rsv direct assay and laboratory-developed real-time pcr assays for detection of respiratory virus'. Together they form a unique fingerprint.

Cite this